Li Yan
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 83
- Cancer Immunotherapy and Biomarkers 45
- Cancer Cells and Metastasis 16
-
- Epigenetics and DNA Methylation 26
- Co-authors
- Kazuaki Takabe (89 shared papers)Masanori Oshi (56 shared papers)Yoshihisa Tokumaru (43 shared papers)Itaru Endo (40 shared papers)Ryusei Matsuyama (31 shared papers)Qianya Qi (20 shared papers)Eriko Katsuta (25 shared papers)Xuan Peng (14 shared papers)
- Journals
- Cancers (19 papers)Oncotarget (10 papers)Scientific Reports (9 papers)International Journal of Molecular Sciences (8 papers)Breast Cancer Research and Treatment (6 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
Li Yan
189 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 142
- Cancer Research 2.2k
- Oncology 2.4k
- Immunology 1.3k
- Molecular Biology 3.3k
- Pulmonary and Respiratory Medicine 1.4k
Countries citing papers authored by Li Yan
This map shows the geographic impact of Li Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Yan more than expected).
Fields of papers citing papers by Li Yan
This network shows the impact of papers produced by Li Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Yan. The network helps show where Li Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 278 | |
| 2 | 2006 | 251 | |
| 3 | 2019 | 223 | |
| 4 | 2012 | 222 | |
| 5 | 2020 | 163 | |
| 6 | 2020 | 139 | |
| 7 | 2019 | 129 | |
| 8 | 2018 | 117 | |
| 9 | 2020 | 110 | |
| 10 | 2013 | 107 | |
| 11 | 2004 | 104 | |
| 12 | 2019 | 97 | |
| 13 | 2020 | 92 | |
| 14 | 2019 | 88 | |
| 15 | KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival. | 2020 | 88 |
| 16 | 2019 | 87 | |
| 17 | 2020 | 85 | |
| 18 | 2019 | 78 | |
| 19 | 2020 | 78 | |
| 20 | 2018 | 77 |
About Li Yan
Li Yan is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 194 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (45 papers), Ferroptosis and cancer prognosis (34 papers), Cancer Genomics and Diagnostics (29 papers), Epigenetics and DNA Methylation (26 papers), Cancer-related molecular mechanisms research (23 papers), MicroRNA in disease regulation (20 papers), Immune cells in cancer (18 papers) and Cancer Cells and Metastasis (16 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (2.4k citations), Immunology (1.3k citations), Molecular Biology (3.3k citations) and Pulmonary and Respiratory Medicine (1.4k citations). Li Yan has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Kazuaki Takabe, Masanori Oshi, Yoshihisa Tokumaru, Itaru Endo, Ryusei Matsuyama, Qianya Qi, Eriko Katsuta, Xuan Peng, Mariko Asaoka and Song Liu. Their work appears in journals such as Cancers, Oncotarget, Scientific Reports, International Journal of Molecular Sciences and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.